
|Slideshows|November 18, 2019
How to Screen & Treat Depression in Patients with Cystic Fibrosis
Author(s)Veronica Hackethal, MD
The burden of poor mental health among CF patients is significant and impacts all aspects of disease management. Test yourself on international best practices for screening and treatment.
Advertisement
Rates of depression and anxiety among people with cystic fibrosis (CF) are known to be high. Prevalence of depression among children and adolescents ranges from ~8% to as high as 29% and among adults from 13% to 33%; prevalence of anxiety among adult CF patients has been found to range from 30% to 33%. Depression carries a risk for suicide and recent data from the Cystic Fibrosis Foundation Registry categorized 1.6% of recorded deaths as from suicide.
Advertisement
Related Content
Advertisement
Advertisement
Trending on Patient Care Online
1
Integrating Social Determinants of Health Into Primary Care: A Team Based Population Health Approach
2
FDA Approves mRNA-1010 (mFLUSIVA) as First mRNA Flu Vaccine for Adults 50 and Older
3
FDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1
4
FDA Reviews Clesrovimab for Second-Season RSV Prevention in High-Risk Children
5






















































































































































